TIPARP and prostate carcinoma: Literature indicates TIPARP can suppress Warburg effect and tumorigenesis by inhibiting HIF-1 [44], exhibits tight regulation by AR signaling in prostate cancer [45, 46], and correlates with antitumor immunity .